Pimozide (Orap) in patients with pseudo-neurotic behaviour
Tanghe, A.J.; Boom, A.J.; Leuridan, P.; Jonckheere, L.; Bruynooghe, F.
Acta Psychiatrica Belgica 77(2): 294-305
1977
ISSN/ISBN: 0300-8967 PMID: 906889 Document Number: 113037
Pimozide 2-12 mg (median 4 mg) was tried for ten weeks in 44 pseudo-neurotic patients. Unsuccessfully used tranquillizers were continued and the use of the antiparkinsonian agent dexetimide was allowed if needed. By the end of the study, a considerable improvement was observed for the vast majority of the items of the Wittenborn psychiatric scale. Their socio-professional adaptation showed a similar tendency. Dexetimide was required in four patients who received high doses of pimozide.